Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TO0472

Order of the President of the General Court of 19 August 2019.
BASF AS v European Commission.
Interim measures — Medicinal product — Marketing authorisation — Omega-3 acid ethyl esters — No urgency.
Case T-472/19 R.

Court reports – general – 'Information on unpublished decisions' section

Order of the President of the General Court of 19 August 2019 –
BASF v Commission

(Case T‑472/19 R)

(Interim measures — Medicinal product — Marketing authorisation —Omega-3 acid ethyl esters — No urgency)

1. 

Application for interim relief — Suspension of operation of a measure — Interim measures — Conditions for granting — Prima facie case — Urgency — Serious and irreparable damage — Cumulative nature — Balancing of all the interests involved — Order of examination and method of verification — Discretion of the court hearing the application for interim relief

(Arts 256(1), 278 and 279 TFEU; Rules of Procedure of the General Court, Art. 156(4))

(see paras 11-14)

2. 

Application for interim relief — Suspension of operation of a measure — Interim measures — Conditions for granting — Urgency — Serious and irreparable damage — Burden of proof — Purely hypothetical damage based on the happening of future and uncertain events — Insufficient to demonstrate urgency

(Arts 278 and 279 TFEU)

(see paras 17, 18)

3. 

Application for interim relief — Suspension of operation of a measure — Interim measures — Conditions for granting — Urgency — Serious and irreparable damage — Burden of proof — Financial loss — Obligation to provide concrete and precise indications, supported by detailed documentary evidence — Situation liable to endanger the existence of the applicant company

(Arts 278 and 279 TFEU; Rules of Procedure of the General Court, Art. 156(4))

(see paras 19-21)

4. 

Application for interim relief — Formal requirements — Submission of applications — Brief summary of the pleas in law on which the application is based — Pleas in law not set out in the application and pleadings — General reference to other documents — Inadmissibility

(Arts 278 and 279 TFEU; Rules of Procedure of the General Court, Art.156(4) and (5))

(see para. 22)

Re:

Application pursuant to Articles 278 TFEU and 279 TFEU for the grant of interim measures to suspend the operation of the Commission Implementing Decision of 6 June 2019 concerning, in the framework of Article 31 of Directive 2001/83/EC, the marketing authorisations of medicinal products for human use containing ‘Omega-3 acid ethyl esters’ for oral use in secondary prevention after myocardial infarction (C(2019) 4336 final).

Operative part

1. 

The application for interim measures is dismissed.

2. 

The costs are reserved.

Top